Cargando…
Liquid Biopsy in Oligometastatic Prostate Cancer—A Biologist's Point of View
Prostate cancer (PCa) is the main cause of cancer-related mortality in males and the diagnosis, treatment, and care of these patients places a great burden on healthcare systems globally. Clinically, PCa is highly heterogeneous, ranging from indolent tumors to highly aggressive disease. In many case...
Autores principales: | Stelcer, Ewelina, Konkol, Marek, Głȩboka, Aleksandra, Suchorska, Wiktoria Maria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6702517/ https://www.ncbi.nlm.nih.gov/pubmed/31475117 http://dx.doi.org/10.3389/fonc.2019.00775 |
Ejemplares similares
-
Chondrocytes differentiated from human induced pluripotent stem cells: Response to ionizing radiation
por: Stelcer, Ewelina, et al.
Publicado: (2018) -
Oligometastatic Prostate Cancer to the Navicular Bone: Case Report
por: Reyes, Diane K., et al.
Publicado: (2015) -
The Prognostic Value of Liquid Biopsies for Benefit of Salvage Radiotherapy in Relapsed Oligometastatic Prostate Cancer
por: Bogdanova, Natalia V., et al.
Publicado: (2022) -
Stereotactic body radiation therapy in the treatment of oligometastatic prostate cancer
por: Ahmed, Kamran A., et al.
Publicado: (2013) -
SBRT: An Opportunity to Improve Quality of Life for Oligometastatic Prostate Cancer
por: Azzam, Gregory, et al.
Publicado: (2015)